The Significance of Immunophenotype on the Evaluation of Myeloid Dysplasia in MDS Patients

doi:10.11748/bjmy.issn.1006-1703.2014.04.023

PDF(923 KB)

Labeled Immunoassays and Clinical Medicine ›› 2014, Vol. 21 ›› Issue (4) : 424. DOI: 10.11748/bjmy.issn.1006-1703.2014.04.023

The Significance of Immunophenotype on the Evaluation of Myeloid Dysplasia in MDS Patients

{{article.zuoZhe_EN}}

Author information +

History +

HeighLight

Abstract

Key words

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2014, 21(4): 424 https://doi.org/10.11748/bjmy.issn.1006-1703.2014.04.023

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

Funding

RIGHTS & PERMISSIONS

PDF(923 KB)

Accesses

Citation

Detail

Sections

Recommended

Received	Revised	Published
2014-01-09	2014-06-03	2014-08-25
Issue Date
2014-09-03

Please choose a citation manager

Content to export

HeighLight

Abstract

Key words

Cite this article

{{custom_sec.title}}

{{custom_sec.title}}

References

References

{{custom_fnGroup.title_en}}

Footnotes

{{custom_ack.title_en}}

Funding

RIGHTS & PERMISSIONS